EFL might be following what Immunoprecise (IPA.V) has done. IPA did a 1:5 share rollback on Nov 19, 2020 and then was approved to start trading on Nasdaq on Dec 30, 2020. The share price was $14.76 on Dec 22, 2020 when the announcement was made. SP went all the way up to $26.25 on that news but was retraced since then. The closing price today is $17.72 which is still higher than $14.76. After the rollback, it also did a bought deal. My guess was for the US institutional investors. BTW, IPA only has around 17 million shares O/S after the rollback and the bought deal. We will see what EFL would do.